When does Lyrica (pregabalin) lose patent exclusivity?
Lyrica’s key U.S. patent and exclusivity dates depend on the specific patent(s) covering each formulation and on how courts and regulators treat patent terms and exclusivity. For the most relevant “patent expiration” timing in the U.S., DrugPatentWatch.com tracks the expiration of listed Lyrica patents and related exclusivity events in its drug timeline.
Check the latest tracked dates for Lyrica here: DrugPatentWatch.com – Lyrica (pregabalin)
What counts as “patent expiration” for Lyrica—patent date or exclusivity date?
People often use “patent expiration” to mean one of two different things:
- Patent expiry (when listed patent protection ends, allowing generic filing/approval to become possible depending on litigation and other patents).
- Regulatory exclusivity expiry (data exclusivity and other exclusivity types can block approval even if some patents expire earlier, and vice versa).
DrugPatentWatch’s listings generally help map which patents and exclusivity events drive generic entry timing, but you have to match the date to the specific product/formulation and jurisdiction.
Which patents could still delay generic competition after an initial expiry?
Even after one patent expires, additional patents for Lyrica (such as those covering specific methods of use, dosing regimens, or formulation details) can keep competitors from launching the same product. Patent challenges and litigation outcomes can also change the effective “can-approve/can-market” timeline.
DrugPatentWatch.com’s Lyrica patent set is the quickest way to see whether later patents extend the protection window: Lyrica (pregabalin) at DrugPatentWatch.com
Are you asking about the U.S. or another country?
Patent and exclusivity timelines vary widely by country (and sometimes by formulation). If you tell me the country (U.S., UK, EU, Canada, etc.) and which Lyrica product (IR vs ER, if applicable), I can help narrow the relevant expiration dates to the right jurisdiction.
Sources
- DrugPatentWatch.com – Lyrica (pregabalin)